Zobrazeno 1 - 10
of 65 128
pro vyhledávání: ''
Publikováno v:
European Radiology; May2024, Vol. 34 Issue 5, p3364-3374, 11p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Krug, Kathrin Barbara, Burke, Christina Jane, Weiss, Kilian, Baltzer, Pascal A. T., Rhiem, Kerstin, Maintz, David, Schlamann, Marc, Hellmich, Martin
Publikováno v:
European Radiology; Jan2022, Vol. 32 Issue 1, p331-345, 15p, 1 Black and White Photograph, 1 Diagram, 6 Charts, 3 Graphs
Publikováno v:
Ginecología y Obstetricia de México; Sep2021, Vol. 89 Issue 9, p688-695, 8p
Autor:
Lajos Pusztai, Gabriel N. Hortobagyi, Bryan T. Hennessy, Massimo Cristofanilli, Chafika Mazouni, Fabrice Andre, Attila Tordai, W. Fraser Symmans, Cornelia Liedtke, Marjorie C. Green, Ana M. Gonzalez-Angulo, Kenneth R. Hess, Jaime A. Mejia
Publikováno v:
Journal of Clinical Oncology. 41:1809-1815
PURPOSE Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) expression. In this study, we compared response to neoadjuvant chemotherap
Publikováno v:
Journal of Clinical Oncology. 41:1331-1338
PURPOSE Immunohistochemistry (IHC) is a newer technique for assessing the estrogen receptor (ER) status of breast cancers, with the potential to overcome many of the shortcomings associated with the traditional ligand-binding assay (LBA). The purpose
Publikováno v:
BMJ case reports. 14(7)
Metastatic cancer to the oesophagus is rare. Most cases are diagnosed at autopsy or surgery. The breast is the most common organ bearing a primary tumour. Metastatic oesophageal tumours are nearly always located in the submucosal layer with normal be
Autor:
Christakoudi, S, Tsilidis, KK, Dossus, L, Rinaldi, S, Weiderpass, E, Antoniussen, CS, Dahm, CC, Tjønneland, A, Mellemkjær, L, Katzke, V, Kaaks, R, Schulze, MB, Masala, G, Grioni, S, Panico, S, Tumino, R, Sacerdote, C, May, AM, Monninkhof, EM, Quirós, JR, Bonet, C, Sánchez, M-J, Amiano, P, Chirlaque, M-D, Guevara, M, Rosendahl, AH, Stocks, T, Perez-Cornago, A, Tin Tin, S, Heath, AK, Aglago, EK, Peruchet-Noray, L, Freisling, H, Riboli, E
Publikováno v:
Christakoudi, S, Tsilidis, K K, Dossus, L, Rinaldi, S, Weiderpass, E, Antoniussen, C S, Dahm, C C, Tjønneland, A, Mellemkjær, L, Katzke, V, Kaaks, R, Schulze, M B, Masala, G, Grioni, S, Panico, S, Tumino, R, Sacerdote, C, May, A M, Monninkhof, E M, Quirós, J R, Bonet, C, Sánchez, M-J, Amiano, P, Chirlaque, M-D, Guevara, M, Rosendahl, A H, Stocks, T, Perez-Cornago, A, Tin Tin, S, Heath, A K, Aglago, E K, Peruchet-Noray, L, Freisling, H & Riboli, E 2023, ' A body shape index (ABSI) is associated inversely with post-menopausal progesterone-receptor-negative breast cancer risk in a large European cohort ', BMC Cancer, vol. 23, no. 1, 562 . https://doi.org/10.1186/s12885-023-11056-1
BACKGROUND: Associations of body shape with breast cancer risk, independent of body size, are unclear because waist and hip circumferences are correlated strongly positively with body mass index (BMI).METHODS: We evaluated body shape with the allomet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ccc128b7b86755b840de6baf6df80fc0
https://pure.au.dk/portal/da/publications/a-body-shape-index-absi-is-associated-inversely-with-postmenopausal-progesteronereceptornegative-breast-cancer-risk-in-a-large-european-cohort(c89b3e83-524a-4a99-8ee7-f4e9aacde3a0).html
https://pure.au.dk/portal/da/publications/a-body-shape-index-absi-is-associated-inversely-with-postmenopausal-progesteronereceptornegative-breast-cancer-risk-in-a-large-european-cohort(c89b3e83-524a-4a99-8ee7-f4e9aacde3a0).html
Publikováno v:
BMC women's health, vol 23, iss 1
Background The early onset of Alzheimer’s disease and related dementias (ADRD) before age 65 can introduce life and health care complications. Preserving an early-onset ADRD patient’s daily functioning longer and delaying declines in health from